Will HIV preventive be a game changer or a missed opportunity?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 40536969.
- Also identified by DOI 10.1126/science.adz8342.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
FDA's anticipated approval of lenacapavir comes at a time of global health cuts.
Medical subject headings
- Acetamides
- Anti-HIV Agents
- HIV Infections
- Indazoles
- Pre-Exposure Prophylaxis